INFLUENCE OF DISSOLUTION CONDITIONS ON THE DISSOLUTION RATE AND RELEASE MECHANISM OF KETOPROFEN FROM EXTENDED RELEASE HYDROPHILIC MATRIX SYSTEMS

被引:3
作者
Casian, Tibor [1 ]
Casian, Andra [1 ]
Gavan, Alexandru [2 ]
Tomuta, Ioan [1 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Dept Pharmaceut Technol & Biopharm, Cluj Napoca 400012, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Dept Med Devices, Cluj Napoca 400349, Romania
关键词
dissolution testing; tablets; extended release; release kinetics; multivariate data analysis; DRUG-RELEASE; SOLUBILITY; HYDRATION; EROSION; PH;
D O I
10.31925/farmacia.2022.2.20
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Development of a hydrophilic matrix based extended release system involves the appropriate selection of polymer type, excipients and active ingredient with suitable physicochemical properties in order to obtain the desired release profile. Considering the multivariate nature of factors affecting the dissolution rate from hydrophilic matrix tablets, this study evaluates the effect of dissolution media, device type and stirring rate on the dissolution rate and release mechanism of ketoprofen from hydroxy-ethylcellulose and hydroxypropylmethylcellulose K4M matrices. The results show that dissolution media type influenced the release rate mostly by limiting solubility, but also by influencing polymer hydration time and solubility. The effect of stirring rate was dependent on device type, dissolution media and product type. Results also show that the selection of device type is an important step in the development of an appropriate dissolution test considering the sticking properties of hydrophilic matrices. Using multivariate data analysis, by developing O2PLS models, the systematic variation between dissolution profiles, kinetic parameters and dissolution conditions was integrated, highlighting joint and unique sources of variations. O2PLS results show that drug release mechanism is mostly influenced by media type, followed by stirring rate and at last by product type.
引用
收藏
页码:331 / 343
页数:13
相关论文
共 28 条
[1]  
[Anonymous], 2007, US PHARM, V30th
[2]   DISSOLUTION KINETIC OF MELOXICAM FROM HYDROPHILIC MATRIX-TYPE FILMS FOR TRANSDERMAL THERAPY [J].
Antonoaea, Paula ;
Redai, Emoke Margit ;
Birsan, Magdalena ;
Tataru, Anamaria ;
Todoran, Nicoleta ;
Vlad, Robert Alexandru ;
Muntean, Daniela-Lucia ;
Ciurba, Adriana .
FARMACIA, 2021, 69 (01) :100-106
[3]  
Aqualon, NATR HYDR NON WAT SO
[4]   Current perspectives in dissolution testing of conventional and novel dosage forms [J].
Azarmi, Shirzad ;
Roa, Wilson ;
Lobenberg, Raimar .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 328 (01) :12-21
[5]   Analysis of surface properties of cellulose ethers and drug release from their matrix tablets [J].
Baumgartner, S ;
Planinsekç, O ;
Srcic, S ;
Kristl, J .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (04) :375-383
[6]   Quantitative evaluation of polymer concentration profile during swelling of hydrophilic matrix tablets using 1H NMR and MRI methods [J].
Baumgartner, S ;
Lahajnar, G ;
Sepe, A ;
Kristl, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (02) :299-306
[7]   Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport [J].
Colombo, P ;
Bettini, R ;
Santi, P ;
DeAscentiis, A ;
Peppas, NA .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :231-237
[8]   DEVELOPMENT AND VALIDATION OF A DISSOLUTION TEST FOR PRIMAQUINE/POLYETHYLENE OXIDE MATRIX TABLETS [J].
Cruz, Ariane P. ;
Bertol, Charise D. ;
Murakami, Fabio S. ;
Pereira, Rafael N. ;
Valente, Bruno R. ;
Silva, Marcos A. S. ;
Koester, Leticia S. .
QUIMICA NOVA, 2013, 36 (03) :407-412
[9]  
Dow, 2006, Using Dow Excipients for Controlled Release of Drugs in Hydrophilic Matrix Systems
[10]  
Eriksson L, 2013, MULTIAND MEGAVARIATE, V3rd, P117